awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38065877-C8D2229F-6151-4050-A890-81A5D474C21B
Q38065877-C8D2229F-6151-4050-A890-81A5D474C21B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38065877-C8D2229F-6151-4050-A890-81A5D474C21B
Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).
P2860
Q38065877-C8D2229F-6151-4050-A890-81A5D474C21B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38065877-C8D2229F-6151-4050-A890-81A5D474C21B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
48f769f73aec758952fecd424d72abfab9588866
P2860
Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H).